跳至主要内容
临床试验/NCT03217487
NCT03217487Unknown不适用

A Randomized Controlled Clinical Trial of Corneal Epithelial Autograft for the Treatment of Limbal Stem Cell Deficiency

Chunxiao Wang1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年7月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Restoration of corneal surface in the diseased eye

研究概览

简要总结

The purpose of the study is to explore whether femtosecond laser-assisted corneal epithelial autograft is more effective than limbal conjunctival autograft for ocular surface reconstruction in patients with limbal stem cell deficiency (LSCD).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Unilateral LSCD secondary to ocular burns, with the duration of disease of at least 24 months at the time of screening visit;
  • Presence of superficial neo-vascularization affecting at least 2 cornea quadrants and involving central cornea;
  • Informed consent signed by patient or legal guardian. Having the ability to comply with study assessments for the full duration of the study.

排除标准

  • LSCD of mild degree, with less than 2 quadrants of neo-vessel invasion and without central cornea involvement;
  • LSCD by ocular surface disorders other than pterygium;
  • Eyelids malposition;
  • The center corneal thickness<450µm, the depth of corneal opacity > 150µm;
  • High myopia with a spherical equivalent of -15.0 D or less;
  • Corneal or ocular surface infection within 30 days prior to study entry;
  • Ocular surface malignancy;
  • Uncontrolled diabetes with most recent Hemoglobin A1c greater than 8.5%;
  • Renal failure with creatinine clearance< 25ml/min;
  • Alanine aminotransferase > 40IU/L, or aspartate aminotransferase > 40IU/L;
  • Platelet levels < 150,000 or > 450,000 per microliter;
  • Hemoglobin < 12.0 g/dL (male) or < 11.0 g/dL (female);
  • Prothrombin time > 16s and activated partial thrombin time > 35s in patients not accepting anticoagulant therapy; An international normalized ratio greater than 3 in patients accepting anticoagulant therapy;
  • Pregnancy (positive test) or lactation;
  • Participation in another simultaneous medical investigation or clinical trial;
  • Severe cicatricial eye disease; Conjunctival scarring with fornix shortening;
  • Ocular comorbidities that affect the prognosis of transplantation, such as advanced glaucoma or retinal diseases;
  • Severe dry eye disease as determined by Schirmer's test < 2mm at least in one eye;
  • Any medical or social condition that in the judgment of the investigator would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent;
  • Signs of current infection, including fever and treatment with antibiotics;
  • Active immunological diseases;
  • History of allo-limbal transplantation, penetrating keratoplasty or anti-glaucoma filtering surgeries.

研究组 & 干预措施

Corneal epithelial autograft

Experimental

Femtosecond laser assisted corneal epithelial autograft from the other eye in the treatment of LSCD

干预措施: Corneal epithelial autograft (Procedure)

Corneal epithelial autograft

Experimental

Femtosecond laser assisted corneal epithelial autograft from the other eye in the treatment of LSCD

干预措施: Femtosecond laser (Device)

Limbal conjunctival autograft

Active Comparator

Diamond knife assisted limbal conjunctival autograft from the other eye in the treatment of LSCD

干预措施: Limbal conjunctival autograft (Procedure)

Limbal conjunctival autograft

Active Comparator

Diamond knife assisted limbal conjunctival autograft from the other eye in the treatment of LSCD

干预措施: Diamond knife (Device)

结局指标

主要结局

Restoration of corneal surface in the diseased eye

时间窗: 1 year

Restoration of a completely epithelized, stable, and avascular corneal surface in the diseased eye.

Restoration of corneal surface in the fellow eye

时间窗: 1 year

Restoration of a completely epithelized, stable, and avascular corneal surface in the fellow eye.

次要结局

  • Uncorrected and best-corrected visual acuity in both eyes(1 year)
  • Corneal power, astigmatism and aberration in both eyes(1 year)
  • Corneal sensation in both eyes(1 year)
  • Corneal thickness in both eyes(1 year)
  • Density of stromal nerve and stromal keratocytes in both eyes(1 year)
  • Reconstruction of limbal palisades of Vogt in the diseased eye(1 year)
  • Corneal haze in both eyes(1 year)

研究者

发起方
Chunxiao Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chunxiao Wang

Clinical investigator

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验